Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

Overview of attention for article published in British Journal of Pharmacology, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent: 4 patents

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 135 Dimensions

Readers on

mendeley: 118 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors modulators

Grant US-11872226-B2

United States of America

GPCR heteromer inhibitors and uses thereof

Grant US-11857600-B2

United States of America

GPCR HETEROMER INHIBITORS AND USES THEREOF

Application EP-3900712-A1

European Patent Office

GPCR heteromer inhibitors and uses thereof

Grant US-10709763-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.